Statistics for Singular Genomics Systems, (id:8387 OMIC)
Valuation metrics
Market cap
53.80M
Enterprise value
-334,908.00
Trailing P/E (ttm)
-0.55
Forward P/E
-0.68
PEG ratio
-0.68
Price/Sales (ttm)
19.76
Price/Book (mrq)
0.29
Enterprise Value/Revenue
-0.12
Enterprise Value/EBITDA
0.00
Overview
Shares outstanding
2.51M
Float
1.43M
Shares short
71.17K
% Held by insiders
0.14%
% Held by institutions
0.60%
Average volume (10 days)
12.88K
Average volume (90 days)
Price summary
52-Week low
5.34
52-Week high
23.41
52-Week change
43.00%
Beta
1.51
50-Day moving average
16.91
200-Day moving average
12.63
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
June 26th, 2024
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-19.17%
Operating margin
-3,094.17%
Operational effectiveness
Return on assets
-24.27%
Return on equity
-51.61%
Income statement
Revenue (ttm)
1.11
Revenue per share (ttm)
1.11
Quarterly revenue growth (yoy)
Gross profit (ttm)
-558,000.00
EBITDA
-93,943,000.00
Net income to common (ttm)
-91,887,000.00
Diluted EPS (ttm)
-34.68
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
133.39M
Total cash per share (mrq)
53.45
Total debt (mrq)
75.73M
Total Debt/Equity (mrq)
54.99
Current ratio (mrq)
877.40%
Book value per share (mrq)
72.74
Cash flow
Cash flow statement
-77,456,000.00
Levered free cash flow (LFCF)
-41,854,752.00